Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism ALK5 inhibitors(Transforming growth factor beta receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | 18 Apr 2023 | |
Triple Negative Breast Cancer | Preclinical | US | 18 Apr 2023 | |
Granulosa Cell Tumor of the Ovary | Preclinical | US | 17 Apr 2023 | |
Ovarian clear cell carcinoma | Preclinical | US | 17 Apr 2023 |